Member Exclusive News

The week in industry: Big blow for Pfizer as the Supreme Court rules against drug patent

This week: AstraZeneca signs US$1.5 billion deal, and collaborations announced to provide more people with HCV treatments and develop immunotherapies for cancer patients.

Go to the profile of RxNet
Nov 15, 2018
0
0

Please sign in or register for FREE

No comments yet.